Floating osmotic drug delivery system of ranitidine hydrochloride: development and evaluation--a technical note.
作者信息
Kumar Pramod, Singh Sanjay, Mishra Brahmeshwar
机构信息
Department of Pharmaceutics, Institute of Technology, Banaras Hindu University, Varanasi 221005, U.P., India.
出版信息
AAPS PharmSciTech. 2008;9(2):480-5. doi: 10.1208/s12249-008-9065-5. Epub 2008 Mar 18.
Abstract
摘要
相似文献
1
Floating osmotic drug delivery system of ranitidine hydrochloride: development and evaluation--a technical note.
AAPS PharmSciTech. 2008;9(2):480-5. doi: 10.1208/s12249-008-9065-5. Epub 2008 Mar 18.
2
Formulation and evaluation of floating tablet of H2-receptor antagonist.
Drug Dev Ind Pharm. 2015;41(9):1499-511. doi: 10.3109/03639045.2014.959969. Epub 2015 Jul 21.
3
Osmotically regulated floating asymmetric membrane capsule for controlled site-specific delivery of ranitidine hydrochloride: optimization by central composite design.
AAPS PharmSciTech. 2012 Dec;13(4):1492-501. doi: 10.1208/s12249-012-9870-8. Epub 2012 Oct 27.
4
In vitro evaluation of Konjac glucomannan as novel excipients for floating systems.
J Control Release. 2011 Nov 30;152 Suppl 1:e34-6. doi: 10.1016/j.jconrel.2011.08.106.
5
Statistical optimization of ranitidine HCl floating pulsatile delivery system for chronotherapy of nocturnal acid breakthrough.
Eur J Pharm Sci. 2009 Jun 28;37(3-4):363-9. doi: 10.1016/j.ejps.2009.03.006. Epub 2009 Mar 24.
6
Chitosan/cellulose acetate microspheres preparation and ranitidine release in vitro.
Pharm Dev Technol. 2005;10(2):219-25. doi: 10.1081/pdt-54421.
7
Evaluation of the tablet core factors influencing the release kinetics and the loadability of push-pull osmotic systems.
Drug Dev Ind Pharm. 2009 Apr;35(4):433-9. doi: 10.1080/03639040802425230.
8
Preparation of Eudragit E100 microspheres by modified solvent evaporation method.
Acta Pol Pharm. 2011 Nov-Dec;68(6):975-80.
9
Controlled release calcium silicate based floating granular delivery system of ranitidine hydrochloride.
Curr Drug Deliv. 2006 Oct;3(4):367-72. doi: 10.2174/156720106778559083.
10
Osmotic-driven release of papaverine hydrochloride from novel poly(decane-co-tricarballylate) elastomeric matrices.
Ther Deliv. 2010 Jul;1(1):37-50. doi: 10.4155/tde.10.2.
本文引用的文献
1
Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation.
Int J Pharm. 2005 Nov 4;304(1-2):178-84. doi: 10.1016/j.ijpharm.2005.08.009. Epub 2005 Sep 29.
2
Oral sustained delivery of atenolol from floating matrix tablets-formulation and in vitro evaluation.
Drug Dev Ind Pharm. 2005 May;31(4-5):367-74. doi: 10.1081/ddc-54313.
3
Development and evaluation of osmotically controlled oral drug delivery system of glipizide.
Eur J Pharm Biopharm. 2004 May;57(3):513-25. doi: 10.1016/j.ejpb.2004.02.003.
4
Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps.
Int J Pharm. 2003 Jun 18;259(1-2):173-9. doi: 10.1016/s0378-5173(03)00230-8.
5
Design of salbutamol EOP tablets from pharmacokinetics parameters.
Pharm Dev Technol. 2003;8(2):135-42. doi: 10.1081/pdt-120018479.
6
Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs.
J Clin Monit Comput. 1999 Dec;15(7-8):529-44. doi: 10.1023/a:1009935116877.
7
Studies on the development of oral colon targeted drug delivery systems for metronidazole in the treatment of amoebiasis.
Int J Pharm. 2002 Apr 2;236(1-2):43-55. doi: 10.1016/s0378-5173(02)00006-6.
8
Colonic metabolism of ranitidine: implications for its delivery and absorption.
Int J Pharm. 2001 Oct 4;227(1-2):157-65. doi: 10.1016/s0378-5173(01)00794-3.
9
Modeling and comparison of dissolution profiles.
Eur J Pharm Sci. 2001 May;13(2):123-33. doi: 10.1016/s0928-0987(01)00095-1.
10
Osmotically controlled oral drug delivery.
Drug Dev Ind Pharm. 2000 Jul;26(7):695-708. doi: 10.1081/ddc-100101287.
Zotero 插件